{"id":"W2699278758","doi":"10.1016/s1470-2045(17)30318-2","title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":570,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"Cancer Research UK","keywords":"Medicine; Chemoradiotherapy; Regimen; Lung cancer; Radiation therapy; Etoposide; Chemotherapy regimen; Internal medicine; Clinical endpoint; Performance status; Surgery; Randomized controlled trial; Chemotherapy; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001390903,0.0003914805,0.001743998,0.00008958431,0.0005141053,0.0001772488,0.001483928,0.0001913051,0.0002949709],"category_scores_gemma":[0.0003652237,0.0002486421,0.00006216083,0.0001584909,0.0007497154,0.0003399276,0.0004178891,0.0008797793,0.0000119118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001314519,"about_ca_system_score_gemma":0.001328954,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003104184,"about_ca_topic_score_gemma":0.004962564,"domain_scores_codex":[0.9968519,0.0005788234,0.0004807605,0.000675016,0.0004903194,0.0009231766],"domain_scores_gemma":[0.9971089,0.0004804021,0.0004262811,0.001425561,0.0002806334,0.0002781883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8900558,0.004505353,0.07243042,0.0002291954,0.0006105194,0.0001351326,0.002352051,0.000004183104,0.0006390958,0.00003632375,0.004513626,0.02448828],"study_design_scores_gemma":[0.9205495,0.01831436,0.01795355,0.0001304172,0.0002799715,0.000001899868,0.0001771046,0.0005043314,0.0004065362,0.000003507843,0.04135223,0.0003266058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807629,0.001177687,0.00001306254,0.005767933,0.001609707,0.006302029,0.0001364504,0.00006005325,0.004170154],"genre_scores_gemma":[0.9913784,0.002560527,0.0001973577,0.001450627,0.00174399,0.001488646,0.00006559295,0.00007466504,0.001040199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05447687,"threshold_uncertainty_score":0.9999966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1504543789406404,"score_gpt":0.4667886956623838,"score_spread":0.3163343167217434,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}